Back to all papers

Deep learning-based classification of benign and malignant breast microcalcifications in mammography.

November 28, 2025pubmed logopapers

Authors

Shia WC

Affiliations (1)

  • Laboratory of Molecular and Surgical Research, Department of Research, Changhua Christian Hospital, 8F., No. 235, XuGuang Road, Changhua, Taiwan. [email protected].

Abstract

The classification of malignant versus benign microcalcifications in mammograms remains a critical yet challenging task in breast cancer screening. Deep learning models, particularly convolutional neural networks, have demonstrated promising results; however, few studies have systematically compared different architectures within this domain. We evaluated the classification performance of two ResNet variants (ResNet-50 and ResNet-101) and five EfficientNet models (B0 to B4) using a five-fold cross-validation framework on 3,674 mammographic slices labelled with BI-RADS 1-2 or 5-6. Performance metrics included accuracy, area under the curve (AUC), and weighted F1-score. We further applied pairwise Wilcoxon signed-rank tests to assess the statistical significance of differences between the models. All EfficientNet models significantly outperformed the ResNet variants in terms of the F1 score (p < 0.05). Among the EfficientNet models, although B3 achieved the highest overall metrics, (accuracy = 86.9%, AUC = 0.998, weighted F1 = 0.869), the performance differences within the EfficientNet group were not statistically significant. EfficientNet-B0 provided comparable performance with much faster inference time. EfficientNet models exhibit superior performance compared to traditional ResNet architectures in the classification of mammographic calcifications. While B3 demonstrated slightly superior performance, B0 may provide a more favourable trade-off between accuracy and inference efficiency. These findings support the integration of lightweight EfficientNet variants into real-world diagnostic workflows.

Topics

Deep LearningMammographyCalcinosisBreast NeoplasmsJournal Article

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.